The immune system is closely associated with both the central nervous system and the endocrine system (Rogers et a!, 1979; Riley, 1981) ; recent develop ments in the psychobiology of the affective dis orders suggest an increase in hypothalamic-pituitary adrenal (HPA) activity in some but not all patients with depression (Carroll, 1982) . This is usually manifested by increases in cortisol levels in plasma, CSF, and urine of depressed patients, compared to normal controls (Carroll eta!, 1976a (Carroll eta!, , 1976b . Other HPA abnormalities in depression include a disruption of the circadian pattern of cortisol secre tion (Sachar et a!, 1973) and plasma cortisol resist ance to suppression by dexamethasone (Carroll, 1982) . Physiologically, this increase in HPA activity in depression may result in a state of hypercorti solaemia, of varying intensity and duration. Since one major effect of hypercortisolaemia is suppres sion of immune function (Dougherty et a!, 1964; Claman, 1972) , and since impaired immunity has been observed in depressed patients (Kronfol et a!, 1983; Schleifer et a!, 1984) , we postulated that depressed patients with hypercortisolaemia will have lower immunological competence than depressed patients without this. To test this hypothesis, we compared immune function in depressed patients with and without hypercortisolaemia and normal controls. The immunological parameter studied was lymphocyteresponse to mitogenstimulationâ€"a correlate ofcell-mediated immunity (Oppenheim et a!, 1975) . HPA activity was assessed with measures of 24-hour urine free cortisol, which is a sensitive indicator of adrenocortical function (Beardwell et a!, 1968; Tyler & West, 1972) and a good index of circulating unbound and physiologically active plasma cortisol levels overtime (Burke & Beardwell, 1973; Carroll eta!, 1976c) . We found that depressed patients had lowerlymphocytic responses than normal controls, but that this lowering of immuno logical competence in depression was not related to increased levels of UFC excretion.
Subjects

Method
Three groups of subjects were identified: (1) depressed patients with hypercortisolaemia (n = 11); (2) depressed patients without hypercortisolaemia (n = 22); and (3) normal controls (n = 20). Hypercortisolaemia was defined, on the basis of UFC excretion, as levels exceeding 100 @g/24hours; this was based on published reports on UFC determinations using similar techniques and showing mean UFC values for the normal population in the range of 33â€"48@ig/24 hours, with less than 5Â°lo of the normal population having values in excess of 100 @ig/24 hrs (Murphy, 1968; Beardwellet a!, 1968; Hsu & Bledsoe, 1970 Table I . Depressed patients TABLEI Demographic features mitogen were used because they were associated with optimal stimulation in dose-response curves obtained earlier in our laboratory. Lymphocytes from all subjects were also cultured without mitogen for background stimu lation. All cultures were incubated at 37Â°Cfor 96 hoursâ€"a culture period determined in our laboratory to provide optimal results; at this point, 1 @iCi of tritiated thymidine was added to each well, and six hours later, the cultures were harvested on to glassfibre filter paper, washed, and air-dried. 
Results
The background (unstimulated) counts for the three study groups were as follows: 346Â±176 cpm for depressed patients with elevated UFC; 835Â±480 cpm for depressed patients with normal UFC and 558Â±288 cpm for normal controls. The lymphocytic responses to the mitogens PHA, Con A, and PWM in the three groups were calcu lated as described above and illustrated in Figure 1 Scale (HDRSâ€"Hamilton, 1960), was not significantly different between the two depressive groups (t = 1.9; df = 31 , NS). All patients and controls were in good physical health and were drug-free for at least two weeks prior to the immune evaluation. Informed consent was obtained from all participants.
Procedure
UFC. Urine collections for 24-hour UFC determina
tions were started on Day 1 at 2300 hours and completed on Day 2 at 2300 hours. Urine volumes were recorded and UFC levels measured using a modified version of the competitive protein-binding assay (Murphy, 1968; Carroll, l976b) . Mean urinary volume in the depressed patients with hypercortisolaemia was 1287Â±651 ml. Mean UFC value in these patients was 147.0Â±34.4@ig/24 hour.
Mean urine volume in depressed patients without hyper cortisolaemia was 1086Â±598 ml. Mean UFC was 60.3Â±20.3pg/24 hours. The difference in urine volume between these two groups was not statistically significant (t = 0.88; df= 31; NS). The difference in 24-hour UFC was highly significant (t=9.l3; df=3l; P<.000l).
Lymphocyte response to mitogen stimulation.
Twenty milliliters of blood were collected from each subject at 0800 hour on Day 2 of thestudy;allsamples were thus drawn during the same 24-hour period of the urine collection. The blood was centrifuged over Ficoll Hypaque and the lymphocytes separated and washed; lymphocytes were then re-suspended in a culture medium (Kronfol et a!, 1983) . Triplicate lymphocyte cultures were established in microtiter plates. To each well were added 10@lymphocytes from the culture medium and one of the following mitogens: Phytohemagglutinin-P (PHA), 25 @g/ml, Concanavalin A (Con A), 10 @ig/ml or Poke and PWM (t = 0.67; df= 31; NS) were not significantly different in these two groups.
We then examined the relation between UFC and lymphocyte function for the entire depressed group (n = 33). Table II shows the results of correlations between 24-hour UFC values and lymphocytic responses to the three different mitogens. There were no significant associations between UFC and lymphocytic responses to any of the mitogens used.
TABLE 11
Correlations between UFC and lymphocyte response to mitogen stimulation in all depressed patients
Our findings also indicate, rather surprisingly, similar lymphocytic responses in depressed patients, regardless of the presence of hypercortisolaemia. Since elevated cortisol levels are usually associated with immunosuppression (Claman, 1972; Britton et a!, 1975) , we had expected depressed patients with elevated UFC to have lower lymphocytic responses than depressed patients with normal UFC, but our data did not support this hypothesis. We also failed to establish any significant .correlation among depressed patients between UFC excretion and lymphocytic responses. Although it is not clear at what level of cortisol the lymphocyte function becomes disturbed, it is possible that the hyper cortisolaemia observed in our depressed patients may not be severe enough to affect the immune response (Fauci, 1978) . It is also possible that depression with hypercortisolaemia is associated with a state of glucocorticoid resistance which minimizes the physiological effects of cortisol (Schlecte & Sherman, 1985) . Alternatively, it is possible that the immunosuppression in depressed patients may not be related to cortisol, but to other hormones or neurotransmitters which have been postulated to play a role in the pathophysiology of depression, such as catecholamines, serotonin, acetylcholine, and endorphins (Van Praag, 1982) .
Since all of these substances have also been shown to regulate the immune response (Hall & Goldstein, 1981) , it is possible that a derangement in the metabolism of one or more of these substances in depression may be responsible for the observed immunological aberrations in depressed patients (Kronfol, 1985; Kronfol & Schlechte, 1985) .
Thus,diminished parameters ofimmune function have been observed in patients with depressive ill ness. The present data indicate that this suppression of immunological competence is not related to an increase in levels of cortisol, an immunosuppressive hormone. We are presently studying the relationship between lymphocyte function and other biological and clinical variables in depressive illness. Further research is needed into the â€˜¿ psychoneuro-immun ology' of the affective disorders and into the relationship betwen hormones, mood, and the immune response in depressed patients to clarify some of these complex issues.
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Discussion
We have earlier reported a suppression of mitogen induced lymphocyte proliferation in patients with depressive illness (Kronfol eta!, 1982; Kronfol eta!, 1983; Kronfol & House, 1984) . These fmdings have alsobeen replicated by independent investigators (Schleifer eta!, 1984) . However, none of the studies published sofar hascomparedlymphocyte function in neuroendocrine sub-types of depression and normal controls. Our data indicate that depressed patients, regardless of cortisol secretion, have lower in-vitro lymphocyte mitogenic responses than normal controls. Lymphocyte response to mitogen stimulation is known to be affected by a number of factors such as age, diurnal variation, medical illness, and drugs. There were no significant differ ences in the age or sex distribution of our depressed patients and normal controls. All subjects were free of drugs or medical illness known to interfere with lymphocyte proliferation in-vitro. All blood samples were collected at the same time of the day to minimize possible effects of diurnal variation.
Severe malnutrition has also been associated with immunosuppression, but our depressed patients were not malnourished (mean weight: 66.4 kgs). It is possible that the stress of hospitalisation may affect immune function, but since most of our patients had been in the hospital for a two-week drug washout period prior to immune testing, the stress of acute hospitalisation wasunlikely tohaveplayed a major role.
